Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs Yum! Brands, Inc. (YUM) Price & Performance

DexCom, Inc.Trade
Yum! Brands, Inc.Trade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs Yum! Brands, Inc. — how do they compare? DexCom, Inc. trades at $77.11 (market cap $28.06B), while Yum! Brands, Inc. trades at $151.44 (market cap $42.05B). The key difference: Yum! Brands, Inc. is the larger of the two by market cap, and Yum! Brands, Inc. pays a 1.97% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.

DXCMYUM
Market Cap
$28.06B$42.05B
Sector
HealthConsumer Cyclical
52-Week High
$89.53$168.16
52-Week Low
$54.84$138.21
Enterprise Value
$27.03B$53.32B
Dividend Yield
1.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DexCom, Inc.

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Yum! Brands, Inc.

YUM Brands trades at $152.32, down 3.73% amid a food safety investigation at Taco Bell. Technical indicators show bearish momentum with support at $151 and resistance at $154. Fundamentally, revenue grew to $8.21B in 2025 with a net income margin of 20.48%, while the P/E ratio stands at 24.61. The company recently announced the $2.7B sale of Pizza Hut to focus on KFC and Taco Bell, alongside a $4B share buyback authorization.

The outlook remains cautious due to near-term headwinds from the health probe, but long-term growth prospects are supported by brand focus and capital returns. Risks include regulatory scrutiny and integration challenges from the divestiture. Analysts maintain a consensus price target of $174.60 with 37% buy ratings, suggesting potential upside if operational stability is restored.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM

About Yum! Brands, Inc.

Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.

Read more on YUM